Viewing data from:

ATOVAQUONE

ANDA

ATOVAQUONE | A214272 | PAI HOLDINGS LLC DBA PHARMACEUTICAL ASSOCIATES INC AND DBA PAI PHARMA

1 strength0 unique patents0 unique exclusivities

Reference Listed Drug: MEPRON(TE code: AB)

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 3 NDCs

Highest NADAC/Unit

$0.7030

per ml

Lowest NADAC/Unit

$0.7030

per ml

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
00121101642ATOVAQUONE 750 MG/5 ML SUSPENSION CUP	$0.7030	ML	Generic	—	2026-06-17
00121095608ATOVAQUONE 750 MG/5 ML SUSP	$0.7030	ML	Generic	—	2026-06-17
00904745953ATOVAQUONE 750 MG/5 ML SUSP CUP	$0.7030	ML	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

VA Federal Supply Schedule

Government-negotiated contract prices | 2 NDCs (2 FSS)

Lowest Price

$634.06

Highest Price

$782.10

FSS NDCs

Big4 NDCs

Description	Price	Type	Vendor	Contract End
00121-1016-18ATOVAQUONE 750MG/5ML SUSP,ORAL	$634.06	FSS	Golden State Medical Supply, Inc.	06/14/2028
00121-1016-42ATOVAQUONE 750MG/5ML SUSP,ORAL	$782.10	FSS	Golden State Medical Supply, Inc.	06/14/2028

Source: VA Federal Supply Schedule (va.gov). Prices are government-negotiated contract prices.

API Supply Chain12 active DMFs7 inactive

10 active API suppliers hold Drug Master Files for this ingredient.

ZYDUS LIFESCIENCES LTDATOVAQUONE USP

DMF 209082007

ALCHYMARS ICM SM PRIVATE LTDATOVAQUONE USP

DMF 220572008

ALIVUS LIFE SCIENCES LTDATOVAQUONE, USP

DMF 221212008

MATRIX PHARMACORP PRIVATE LTDATOVAQUONE USP

DMF 221342008

HETERO DRUGS LTDATOVAQUONE (FORM-A)

DMF 244462010

TARO PHARMACEUTICAL INDUSTRIES LTDATOVAQUONE USP, MICRONIZED

DMF 269062013

ALIVUS LIFE SCIENCES LTDATOVAQUONE USP (D144 PROCESS)

DMF 311422016

APITORIA PHARMA PRIVATE LTDATOVAQUONE USP

DMF 316752017

NURAY CHEMICALS PRIVATE LTDATOVAQUONE USP

DMF 363392021

HETERO DRUGS LTDATOVAQUONE (FORM-A), PROCESS II

DMF 409522024

IPCA LABORATORIES LTDATOVAQUONE USP

DMF 422012025

SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO LTDATOVAQUONE

DMF 436222026

USV LTDInactiveATOVAQUONE USP

DMF 206722007

ZHEJIANG HISOAR PHARMACEUTICAL CO LTDInactiveAtovaquone

DMF 210012007

ROLABO OUTSOURCING SLInactiveATOVAQUONE USP

DMF 213602008

EXCELLA GMBHInactiveATOVAQUONE

DMF 214682008

USV PRIVATE LTDInactiveATOVAQUONE USP (FORM III)

DMF 235132010

USV PRIVATE LTDInactiveATOVAQUONE USP (FORM I)

DMF 235562010

SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO LTDInactiveATOVAQUONE

DMF 253052011

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — 750MG/5ML

0 patents0 exclusivities▴

SUSPENSION;ORAL | Approved: Oct 25, 2021

No patent or exclusivity listings for this strength.